OpenVSafe by OpenVAERS
Search V-safe

PW9-18861-07741

3 vaccinations 3 coded responses 13 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
209 / MD
Registered
2021-10-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-25
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-18
    Dose 2 — Pfizer-BioNTech
  3. 2021-10-22
    Dose 3 — Pfizer-BioNTech
  4. 2021-10-25
    Registered in v-safe
  5. 2021-10-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Vaginal haemorrhage — Feeling: Good
    Free text: Vaginal spotting
    MedDRA releases: 2024-11 · check-in free text available
  6. 2021-10-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  7. 2021-10-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  8. 2021-10-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-10-29
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-11-05
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  11. 2021-11-12
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  12. 2021-11-19
    Survey response — day 28, dose 3
    MedDRA: Pelvic organ prolapse — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Pelvic floor prolapse
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-11-19
    Report sent to call center — day 28, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  14. 2021-11-24
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  15. 2021-11-26
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  16. 2021-12-03
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-01-21
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-04-22
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-10-22
    Survey response — 12 months, dose 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Good
    Free text: Runny nose and mild cough
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-02-25Pfizer-BioNTech No
22021-03-18Pfizer-BioNTech No
32021-10-22Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-25

Systemic reaction (other): Vaginal spotting

Release 10 — day 28, dose 3

2021-11-19

Symptoms: Pelvic floor prolapse

Release 12 — 12 months, dose 3

2022-10-22

Symptoms: Runny nose and mild cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDPelvic organ prolapse · · ✓
SDRhinorrhoea · · ✓
SROVaginal haemorrhage · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release